Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
‘In It For The Long Haul‘ – Celltrion Remains Committed To US Biosimilars
Chief Commercial Officer Talks Humira Competition And Future Launch Plans
Jun 24 2024
•
By
David Wallace
Celltrion says it is committed to the US biosimilars market • Source: Shutterstock
More from Biosimilars
More from Products
